Physician

Aras Emdadi, DO

According to 2025 Medicare claims, Aras Emdadi, DO (NPI: 1477997336) practices colorectal surgery (formerly proctology) in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is NURICK SURGICAL INSTITUTE INC (NPI: 1770659278; TIN: 330730439) and primary practice location at 92501-4135.

Emdadi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 337 HCPCS/CPT codes, and received $65,560 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 210 prescription claims across 107 beneficiaries totaling $1,925 in drug costs, led by Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl). Open Payments data shows 17 records totaling $1,603. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,497 to $1,925. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$35K$71K2021 Medicare payment: $17,543 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $57,336 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $70,921 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $65,560 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213992$17,543
2022105276$57,336
2023132323$70,921
2024155337$65,560

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$968$1.9K2015 Drug cost: $1,497 (USD; Tot_Drug_Cst)2016 Drug cost: $862 (USD; Tot_Drug_Cst)2017 Drug cost: $297 (USD; Tot_Drug_Cst)2018 Drug cost: $140 (USD; Tot_Drug_Cst)2019 Drug cost: $495 (USD; Tot_Drug_Cst)2020 Drug cost: $1,246 (USD; Tot_Drug_Cst)2021 Drug cost: $1,290 (USD; Tot_Drug_Cst)2022 Drug cost: $1,937 (USD; Tot_Drug_Cst)2023 Drug cost: $1,849 (USD; Tot_Drug_Cst)2024 Drug cost: $1,925 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152237$1,497
20162833$862
20171923$297
20181823$140
2019N/R13$495
202044113$1,246
20214787$1,290
202269124$1,937
202390172$1,849
2024107210$1,925

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes5759$138
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2727$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2326$98
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes3054$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3135$69

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl2637$431
Neomycin SulfateNeomycin Sulfate6468$340
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl1116$207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15100$146
MetronidazoleMetronidazole6466$89

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$1,603INTUITIVE SURGICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aras Emdadi, DO?

Tedicare shows public-source Medicare data for Aras Emdadi, DO (NPI 1477997336), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aras Emdadi, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aras Emdadi, DO?

Aras Emdadi, DO is linked to NURICK SURGICAL INSTITUTE INC (billing NPI 1770659278) in the available physician profile data.

Does Aras Emdadi, DO have Open Payments data?

Aras Emdadi, DO has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.